Cart
sales@molnova.com
PF-03814735
CAS No. 942487-16-3
PF-03814735 ( —— )
Catalog No. M17679 CAS No. 942487-16-3
PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 706 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-03814735
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.
-
DescriptionPF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAurora A; Aurora B;FLT1 ;FAK; TrkA
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number942487-16-3
-
Formula Weight474.48
-
Molecular FormulaC23H25F3N6O2
-
Purity98%
-
SolubilityDMSO : ≥ 47 mg/mL; 99.06 mM
-
SMILESCC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Macrozamin
Macrozamin has carcinogenic, mutagenic, teratogenic and neurotoxic properties.Macrozamin is a natural product isolated from Cycads.?
-
Alloisoimperatorin
Alloisoimperatorin is a candidate of AChE inhibitors, it displays potent antioxidant effects against the DPPH radical and against renal epithelial cell injury by using AAPH to generate peroxyl radicals in vitro.
-
3-(2-Hydroxyphenyl)-...
3-(2-Hydroxyphenyl)-2-propenal is a natural product for research related to life sciences.
